openPR Logo
Press release

Asia-Pacific IVD Market Poised to Surpass $36.02 Billion by 2031

02-08-2024 12:55 PM CET | Health & Medicine

Press release from: Meticulous Research®

/ PR Agency: Meticulous Research
Asia-Pacific IVD Market Poised to Surpass $36.02 Billion by 2031

Meticulous Research® Unveils Groundbreaking Insights into the Asia-Pacific IVD Market

Meticulous Research®, a renowned global market research firm, proudly presents its latest research report titled, 'Asia-Pacific IVD Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach - Forecast to 2031.'

Download Complete Free Sample PDF Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5750

Asia-Pacific IVD Market Set to Skyrocket

According to this groundbreaking publication, the Asia-Pacific IVD market is poised to surge to $36.02 billion by 2031, registering a remarkable CAGR of 7% from 2024 to 2031. This growth trajectory is underpinned by several factors, including the escalating prevalence of chronic and infectious diseases, surging demand for point-of-care (PoC) and rapid diagnostics, increasing awareness regarding early disease diagnosis, burgeoning healthcare expenditures, and escalating funding for research endeavors.

Pioneering Insights and Market Dynamics

While the Asia-Pacific IVD market is on an upward trajectory, it faces challenges such as stringent technical requirements and regulatory processes for high/moderate-complexity tests and variability in test results observed in rapid IVD tests. However, the market is ripe with opportunities, particularly driven by the burgeoning trend towards personalized medicine and advancements in genomics and proteomics.

Check complete table of contents with list of table and figures: https://www.meticulousresearch.com/product/asia-pacific-ivd-market-5750

Key Market Players

Leading the charge in this dynamic market landscape are key players including Abbott Laboratories, Becton, Dickinson and Company, Sysmex Corporation, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., and many others.

A Glimpse into the Future

The Asia-Pacific IVD market is meticulously analyzed and segmented by offering, technology, application, diagnostic approach, and end user, providing a comprehensive outlook into the market dynamics. Among the segments, the reagents & kits segment is poised to dominate the market, driven by the need for accurate and user-friendly diagnostic solutions.

Quick Buy : https://www.meticulousresearch.com/Checkout/80953995

Geographic Analysis

This comprehensive report delves into major countries including China, Japan, India, Australia, South Korea, Thailand, Singapore, Indonesia, and the Rest of Asia-Pacific. China, in particular, is expected to lead the charge, buoyed by factors such as rising chronic diseases prevalence and government support for routine tests.

Join the Journey Towards a Healthier Future

Embark on a journey towards a healthier tomorrow by accessing our transformative insights into the Asia-Pacific IVD market. Download the sample report now and stay ahead of the curve.

Have Any Query? Ask To Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5750

#Research #PowerGeneration #FossilFuel #HydroStorage #HydrogenMarket #EnergyTransition #Innovation #Sustainability

Asia-Pacific
Office No-202, 203,204,205,206
2nd Floor, Pushpak Business Hub,
Wakad, Pimpri-Chinchwad,
411057, India.

We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia-Pacific IVD Market Poised to Surpass $36.02 Billion by 2031 here

News-ID: 3377949 • Views:

More Releases from Meticulous Research®

Meticulous Research® Releases Comprehensive Report on the Monoclonal Antibodies …
Meticulous Research®, a globally recognized leader in market research, has announced the release of its latest report titled, Monoclonal Antibodies Market Size, Share, Forecast & Trends Analysis by Type (Therapeutic, Research, Diagnostic), Application (Oncology, Immunology, Cardiology, Neurology), Source (Humanized, Murine, Human), Production, End User - Global Forecast to 2031. This in-depth analysis projects the global monoclonal antibodies market to reach $449.8 billion by 2031, growing at a CAGR of 11.2%
Meticulous Research® Releases Comprehensive Report on the Lab-Grown Meat Market …
Meticulous Research®, a globally recognized leader in market research and analysis, has recently published its latest report titled "Lab-grown Meat Market by Type (Beef, Poultry, Pork, Seafood), Distribution Channel (Business-to-Business, Business-to-Consumer), Application (Nuggets, Burger Patties, Meatballs, Steak, Hot Dogs & Sausages), and Geography-Global Forecast to 2035." Download Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5293 According to the report, the global lab-grown meat market is expected to reach an estimated valuation of $1.99 billion by
Workforce Management Market Trends: Key Drivers, Challenges, and Opportunities in 2024 and Beyond
Workforce Management Market Trends: Key Drivers, Challenges, and Opportunities i …
According to a recent report by Meticulous Research®, the global Workforce Management Market is projected to reach a valuation of $9.8 billion by 2031, with a compound annual growth rate (CAGR) of 11.3% from 2024 to 2031. This rapid growth can be attributed to the increasing adoption of cloud-based workforce management solutions, growing interest in workforce scheduling and optimization, and a broadening application of these solutions across various industries. However,
Global Lipid Nutrition Market Poised for Robust Growth: Projected to Reach $24.71 Billion by 2030
Global Lipid Nutrition Market Poised for Robust Growth: Projected to Reach $24.7 …
According to the latest report from Meticulous Research®, the global lipid nutrition market is set to achieve remarkable growth, with projections estimating the market will reach $24.71 billion by 2030. This expansion, anticipated to occur at a compound annual growth rate (CAGR) of 8.9% from 2023 to 2030, is driven by several key factors, including rising chronic disease rates, an aging population, and increasing demand for dietary supplements and infant

All 5 Releases


More Releases for IVD

IVD Market 2021 | Detailed Report
The IVD market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The IVD report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period. The IVD research report also provides insights of different regions that are contributing market growth.
Liquid Biopsy IVD Market 2021 | Detailed Report
According to Market Study Report, Liquid Biopsy IVD Market provides a comprehensive analysis of the Liquid Biopsy IVD Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of Liquid Biopsy IVD Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4623688 The report provides a
Infectious Disease IVD Market – Forecast to 2026
The findings reviewed by GME stated that the Global Infectious Disease In-Vitro Diagnostics Market would grow at a CAGR value of 4.6 percent from 2021 to 2026. The increasing geriatric population is the primary driving factor for the infectious disease in-vitro diagnostics market. Besides, the increasing number of infectious diseases, launch of advanced testing kits and beneficial features attributed by IVDs are propelling growth in the market. Browse 159 Market
Asia IVD Market
According to a new report published by Allied Market Research, the Asia Pacific In-vitro diagnostics market was valued at $12.9 billion in 2015, and is expected to reach $19.0 billion registering a CAGR of 5.6% during 2016 to 2022. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario. Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1256 The Asia-Pacific IVD market is
LAMEA IVD Market | Business Development Strategies
LAMEA IVD market size was valued at $7,413 million in 2016, and is projected to reach at $10,316 million by 2023, growing at a CAGR of 4.7% from 2017 to 2023. The immunodiagnostics segment accounted for more than two-ninths share of the total market in 2016. Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/4137 In vitro diagnostics (IVD) are medical devices and reagents used for examination of the body samples such as blood, tissue, and
Global IVD Products Market Research Report
This report studies the global IVD Products market status and forecast, categorizes the global IVD Products market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Abbott Laboratories Danaher Corporation Johnson and Johnson Roche Diagnostics Siemens Healthcare BD Biomerieux Bio-Rad Laboratories Ortho Clinical